ENSG vs KNSA: fair value comparison
The Ensign Group, Inc. and Kiniksa Pharmaceuticals International, plc · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, ENSG currently sits closer to the top of our discount ranking.
| ENSG | KNSA | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $177.23 | $73.41 |
| 12-month range | $164.82–$215.67 | $34.28–$73.41 |
| Sector rank | #56 of 113 Healthcare | #58 of 113 Healthcare |
| Quality grade | D | D |
| Leverage | Moderate | Low |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| 52-week position | The bottom quarter | The top quarter |
Full single-stock breakdowns: ENSG fair value analysis · KNSA fair value analysis